Japan
· Delayed Price · Currency is JPY EnBio Holdings Statistics
Total Valuation
EnBio Holdings has a market cap or net worth of JPY 4.64 billion. The enterprise value is 11.32 billion.
| Market Cap | 4.64B |
| Enterprise Value | 11.32B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
EnBio Holdings has 8.08 million shares outstanding. The number of shares has increased by 6.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 8.08M |
| Shares Change (YoY) | +6.30% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 19.67% |
| Owned by Institutions (%) | 5.07% |
| Float | 3.65M |
Valuation Ratios
The trailing PE ratio is 5.01.
| PE Ratio | 5.01 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 0.52 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.19 |
| EV / Sales | 1.05 |
| EV / EBITDA | 6.86 |
| EV / EBIT | 9.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.62 |
| Quick Ratio | 1.06 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 9.05 |
Financial Efficiency
Return on equity (ROE) is 10.57% and return on invested capital (ROIC) is 4.10%.
| Return on Equity (ROE) | 10.57% |
| Return on Assets (ROA) | 3.74% |
| Return on Invested Capital (ROIC) | 4.10% |
| Return on Capital Employed (ROCE) | 7.68% |
| Revenue Per Employee | 103.66M |
| Profits Per Employee | 8.93M |
| Employee Count | 104 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 2.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.20% in the last 52 weeks. The beta is 0.79, so EnBio Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -3.20% |
| 50-Day Moving Average | 585.64 |
| 200-Day Moving Average | 601.50 |
| Relative Strength Index (RSI) | 50.89 |
| Average Volume (20 Days) | 15,955 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EnBio Holdings had revenue of JPY 10.78 billion and earned 928.52 million in profits. Earnings per share was 114.47.
| Revenue | 10.78B |
| Gross Profit | 2.92B |
| Operating Income | 1.18B |
| Pretax Income | 1.39B |
| Net Income | 928.52M |
| EBITDA | 1.65B |
| EBIT | 1.18B |
| Earnings Per Share (EPS) | 114.47 |
Balance Sheet
The company has 3.38 billion in cash and 9.97 billion in debt, giving a net cash position of -6.59 billion or -815.35 per share.
| Cash & Cash Equivalents | 3.38B |
| Total Debt | 9.97B |
| Net Cash | -6.59B |
| Net Cash Per Share | -815.35 |
| Equity (Book Value) | 8.98B |
| Book Value Per Share | 1,100.22 |
| Working Capital | 3.37B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 10.98% |
| Pretax Margin | 12.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.30% |
| Shareholder Yield | -4.91% |
| Earnings Yield | 20.02% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |